NK-1 receptor antagonist
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NK-1 receptor antagonist, covering 2023-05-03 to 2023-05-03. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer [Phase 4]